View Older Stories View More Recent Stories

May 30, 2017 05:01AM Chardan Capital Markets Starts Assembly Biosciences (ASMB) at Buy, "Sensitivity analyses suggest considerable upside"
May 24, 2017 07:30AM Spring Bank Pharmaceuticals (SBPH) PT More than Doubled to $34 at Chardan Capital Markets
May 22, 2017 04:30PM Castlight Health to Participate in Upcoming Investor Conferences
May 19, 2017 06:06AM Chardan Capital Markets Starts Model N, Inc. (MODN) at Buy; Undervalued Versus Peers
May 17, 2017 09:38AM Smith Micro (SMSI) Announces $2.2M Registered Direct Offering of Common Stock
May 17, 2017 09:38AM Smith Micro Announces $2.2 Million Registered Direct Offering of Common Stock
May 15, 2017 09:37AM Alnylam Pharmaceuticals (ALNY) PT Raised to $110 at Chardan Capital Markets
May 11, 2017 07:11AM Chardan Capital Markets Downgrades CaesarStone Sdot-Yam (CSTE) to Neutral on Valuation
May 10, 2017 05:27PM Astrotech (ASTC) Subsidiary to Pursue Strategic Alternatives
May 10, 2017 05:24PM Astrotech Subsidiary 1st Detect to Pursue Strategic Alternatives
May 5, 2017 10:07AM Alnylam Pharmaceuticals (ALNY) PT Trimmed to $95 at Chardan Capital Markets
May 4, 2017 09:34AM Lion Biotechnologies (LBIO) PT Raised to $20 at Chardan Capital Markets, "Leader In Precision Immuno-Oncology"
May 1, 2017 04:27PM Chardan Capital Markets Starts Spring Bank Pharmaceuticals (SBPH) at Buy; Can Lead in HBV
Apr 28, 2017 04:00PM Forum Merger Corporation Class A Common Stock, Warrants and Rights to Commence Trading Separately on May 2, 2017
Apr 26, 2017 04:01PM REGENXBIO Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
Apr 24, 2017 12:01PM Chardan Capital Markets Reiterates Sell Rating and $6.50 PT on Akari Therapeutcis (AKTX); 'Weak Efficacy for Coversin in the Ph2 PNH COBALT Trial'
Apr 21, 2017 09:42AM SRAX Announces Offering of $3.72 Million of Secured Convertible Debentures
Apr 17, 2017 05:55AM Akari Therapeutics (AKTX) PT Raised to $6.50 at Chardan Capital Markets; 'Skepticism on Coversin in PNH'
Apr 12, 2017 04:34PM Forum Merger Corporation Completes $150,000,000 Initial Public Offering
Apr 12, 2017 08:38AM PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
Apr 12, 2017 06:29AM Lion Biotechnologies (LBIO): Reiterating Buy - Chardan
Apr 11, 2017 05:55AM Regenxbio Inc. (RGNX) PT Raised to $50 at Chardan Capital Markets on News Dr. Olivier Danos is New CSO; 'Watershed Moment'
Apr 10, 2017 04:01PM Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock and Warrants
Apr 6, 2017 08:01PM Forum Merger Corporation Announces Pricing of $150 Million Initial Public Offering
Apr 5, 2017 09:24AM Ohr Pharmaceutical (OHRP) Prices $14.175M Offering of Common Stock and Warrants
Apr 5, 2017 09:23AM Ohr Pharmaceutical Announces Pricing of $14.175 Million Public Offering of Common Stock and Warrants
Apr 4, 2017 04:03PM Ohr Pharmaceutical (OHRP) Reports Proposed Equity Offering
Apr 4, 2017 04:01PM Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
Apr 4, 2017 09:29AM Pre-Open Movers 04/04: (GNCMA) (PRTK) (CYCC) Higher; (AYI) (KATE) (NVDA) Lower (more...)
Apr 4, 2017 06:00AM Chardan Capital Markets Upgrades Arbutus Biopharma (ABUS) to Buy
Mar 31, 2017 09:00AM WPCS Closes $968,000 Financing
Mar 30, 2017 06:32AM Ritter Pharma (RTTR): Cutting PT After Phase II Data Fails To Meet Endpoint - Chardan
Mar 28, 2017 09:29AM Pre-Open Movers 03/28: (PSIX) (CARA) (SB) Higher; (CYRX) (ORIG) (MEET) Lower (more...)
Mar 28, 2017 09:11AM Biocept (BIOC) to Sell 4.32M Shares at $2.15 with Warrants
Mar 28, 2017 09:10AM Biocept Announces Pricing of $9.3 Million Financing
Mar 27, 2017 05:56PM After-Hours Stock Movers 03/27: (PSIX) (OCN) (RHT) Higher; (CYRX) (EVH) (STOR) Lower (more...)
Mar 27, 2017 04:33PM Chardan Capital Markets Starts CRISPR Therapeutics (CRSP) at Buy
Mar 27, 2017 04:31PM Chardan Capital Markets Starts Editas Medicine (EDIT) at Buy
Mar 27, 2017 04:30PM Chardan Capital Markets Starts Intellia Therapeutics (NTLA) at Buy
Mar 27, 2017 06:18AM Teladoc (TDOC): Management Confident on NDR - Chardan
Mar 23, 2017 08:01AM La Jolla Pharmaceutical (LJPC) Prices 3.7M Common Stock Offering at $33.50/Share
Mar 23, 2017 08:00AM La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock
Mar 22, 2017 06:30AM HealthEquity, Inc (HQY) PT Raised to $53 at Chardan Capital Markets Following Q4 Beat and Positive Guidance
Mar 22, 2017 05:36AM Regenxbio (RGNX) Reports Pricing of 3.7M Share Offering at $20.50
Mar 21, 2017 09:31PM REGENXBIO Announces Pricing of Public Offering of Common Stock
Mar 21, 2017 04:03PM Regenxbio (RGNX) Plans $75M Common Stock Offering
Mar 21, 2017 04:01PM REGENXBIO Announces Proposed Public Offering of Common Stock
Mar 15, 2017 07:18AM Chardan Capital Markets Reiterates Buy on Benefitfocus (BNFT) Following Analyst Day
Mar 13, 2017 08:29AM Chardan Capital Markets Reiterates Buy on Cogent (COGT) Following 4Q
Mar 13, 2017 05:56AM Profire Energy (PFIE) PT Raised to $2.15 at Chardan Capital Markets; Estimates Raised
View More Recent Stories View Older Stories